Journal article

Stem cell therapy for Alport syndrome: the hope beyond the hype

Oliver Gross, Dorin-Bogdan Borza, Hans-Joachim Anders, Christoph Licht, Manfred Weber, Stephan Segerer, Roser Torra, Marie-Claire Gubler, Laurence Heidet, Scott Harvey, Dominic Cosgrove, George Lees, Clifford Kashtan, Martin Gregory, Judy Savige, Jie Ding, Paul Thorner, Dale R Abrahamson, Corinne Antignac, Karl Tryggvason Show all

NEPHROLOGY DIALYSIS TRANSPLANTATION | OXFORD UNIV PRESS | Published : 2009

Grants

Awarded by NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES


Funding Acknowledgements

C. K. is the executive director of the Alport Syndrome Treatments and Outcomes Registry (ASTOR), USA. O.G. is the principal investigator of the European Alport therapy registry, supported by the Association pour l'Information et la Recherche sur les maladies renale Genetiques France and the KfH-Foundation Preventive Medicine.